MAPK8 and AL amyloidosis: Berbamine also effectively inhibits the growth of RPMI 8226 human multiple myeloma cells, which is associated with the activation of the GADD45/JNK signalling pathway, apoptosis and upregulation of p53, p21 and GADD45gamma mRNA [17].